Abstract
Primary vesicoureteric reflux was felt to result from a congenitally short mucosal tunnel length with oblique intravescical insertion but more recent data suggest that primary vesicoureteric reflux is often associated with functional urodynamic abnormalities. There is now sound evidence that primary vesicoureteric reflux has a familial basis; most findings suggest a dominant inheritance with incomplete penetrance. Primary vesicoureteric reflux is often associated with kidney damage, mostly referred to as reflux nephropathy. It has been traditionally assumed that in primary vesicoureteric reflux kidney damage results from reflux of infected urine into the renal tissue but recent observations indicate that kidney damage sometimes occurs prenatally. In the overwhelming majority of patients with prenatally acquired renal damage the damage is linked with high-grade vesicoureteric reflux. In conclusion there are two categories of reflux disorder: a reflux associated with an acquired renal scarring secondary to infections and a prenatal high-grade vesicoureteric reflux linked with a congenital nephropathy.
Keywords: Reflux nephropathy, Urinary tract infection, Vesicoureteric reflux, Bladder dysfunction
Current Pediatric Reviews
Title: Primary Vesicoureteric Reflux and Reflux Nephropathy - New Insights
Volume: 2 Issue: 2
Author(s): Laura Santoro, Alessandra Ferrarini, Laura Crosazzo and Mario G. Bianchetti
Affiliation:
Keywords: Reflux nephropathy, Urinary tract infection, Vesicoureteric reflux, Bladder dysfunction
Abstract: Primary vesicoureteric reflux was felt to result from a congenitally short mucosal tunnel length with oblique intravescical insertion but more recent data suggest that primary vesicoureteric reflux is often associated with functional urodynamic abnormalities. There is now sound evidence that primary vesicoureteric reflux has a familial basis; most findings suggest a dominant inheritance with incomplete penetrance. Primary vesicoureteric reflux is often associated with kidney damage, mostly referred to as reflux nephropathy. It has been traditionally assumed that in primary vesicoureteric reflux kidney damage results from reflux of infected urine into the renal tissue but recent observations indicate that kidney damage sometimes occurs prenatally. In the overwhelming majority of patients with prenatally acquired renal damage the damage is linked with high-grade vesicoureteric reflux. In conclusion there are two categories of reflux disorder: a reflux associated with an acquired renal scarring secondary to infections and a prenatal high-grade vesicoureteric reflux linked with a congenital nephropathy.
Export Options
About this article
Cite this article as:
Santoro Laura, Ferrarini Alessandra, Crosazzo Laura and Bianchetti G. Mario, Primary Vesicoureteric Reflux and Reflux Nephropathy - New Insights, Current Pediatric Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339606776894676
DOI https://dx.doi.org/10.2174/157339606776894676 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)
Current Pharmaceutical Design Comparison of Dietary Approaches to Treat Obesity Based on the Different Carbohydrate/Fat Content: Impact on Weight Loss and Lipid Profile
Current Nutrition & Food Science Calcium Ion – The Key Player in Cerebral Ischemia
Current Medicinal Chemistry Stroke Outcomes in Mice Lacking the Genes for Neuronal Heme Oxygenase-2 and Nitric Oxide Synthase
Current Neurovascular Research Vascular Calcifications in Chronic Kidney Disease: Are There New Treatments?
Current Vascular Pharmacology Angiogenesis-regulating microRNAs and Ischemic Stroke
Current Vascular Pharmacology The Application of Proteomics in Neurology
Current Proteomics Atrial Macroreentry in Congenital Heart Disease
Current Cardiology Reviews Recent Patents on PCSK9: A New Target for Treating Hypercholesterolemia
Recent Patents on DNA & Gene Sequences Liver Disease in Diabetes Mellitus: Potential Therapeutic Value of Vitamin E-Silybin Phytosomal Complex
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease
Current Vascular Pharmacology Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Di-hydropyridine Analogs as Potent Antioxidants
Current Topics in Medicinal Chemistry Obstructive Sleep Apnea in Chronic Obstructive Pulmonary Disease: The Overlap Syndrome
Current Respiratory Medicine Reviews Levosimendan Preoperative
Current Pharmaceutical Design Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Improving Patient Compliance with Hypertension Treatment: Mission Possible?
Current Vascular Pharmacology Antiarrhythmic Therapy on Prevention of Postoperative Atrial Fibrillation in Patients After Heart Surgery
Current Medicinal Chemistry - Cardiovascular & Hematological Agents A Review on the Pharmacology and Toxicology of Steviol Glycosides Extracted from Stevia rebaudiana
Current Pharmaceutical Design Signaling Epicenters: The Role of Caveolae and Caveolins in Volatile Anesthetic Induced Cardiac Protection
Current Pharmaceutical Design The Incidence of Adverse Drug Reactions in Patients Treated with Statins in the Emirates: A Retrospective Cohort Study
Current Vascular Pharmacology